212 related articles for article (PubMed ID: 20703889)
1. The first 3 months after BCNU wafers implantation in high-grade glioma patients: clinical and radiological considerations on a clinical series.
Della Puppa A; Rossetto M; Ciccarino P; Del Moro G; Rotilio A; Manara R; Paola Gardiman M; Denaro L; d'Avella D; Scienza R
Acta Neurochir (Wien); 2010 Nov; 152(11):1923-31. PubMed ID: 20703889
[TBL] [Abstract][Full Text] [Related]
2. Carmustine wafer implantation when surgical cavity is communicating with cerebral ventricles: technical considerations on a clinical series.
Della Puppa A; Rossetto M; Ciccarino P; Denaro L; Rotilio A; d'Avella D; Scienza R
World Neurosurg; 2011; 76(1-2):156-9; discussion 67-8. PubMed ID: 21839967
[TBL] [Abstract][Full Text] [Related]
3. Patterns of Recurrence After Resection of Malignant Gliomas With BCNU Wafer Implants: Retrospective Review in a Single Institution.
Shimato S; Nishizawa T; Ohshima T; Imai T; Goto S; Yamamoto T; Kato K
World Neurosurg; 2016 Jun; 90():340-347. PubMed ID: 26960286
[TBL] [Abstract][Full Text] [Related]
4. [Risk Factors for Adverse Events after Implantation of BCNU Wafers in High-grade Gliomas].
Yoshida M; Yamaguchi S; Ishi Y; Endo S; Motegi H; Kobayashi H; Asaoka K; Kamoshima Y; Terasaka S; Houkin K
No Shinkei Geka; 2015 Jul; 43(7):603-10. PubMed ID: 26136324
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of brain edema in patients with malignant glioma treated with BCNU wafers.
Murai S; Ichikawa T; Kurozumi K; Shimazu Y; Oka T; Otani Y; Shimizu T; Date I
J Clin Neurosci; 2016 Nov; 33():148-153. PubMed ID: 27452129
[TBL] [Abstract][Full Text] [Related]
6. The surgical bed after BCNU polymer wafer placement for recurrent glioma: serial assessment on CT and MR imaging.
Hammoud DA; Belden CJ; Ho AC; Dal Pan GJ; Herskovits EH; Hilt DC; Brem H; Pomper MG
AJR Am J Roentgenol; 2003 May; 180(5):1469-75. PubMed ID: 12704070
[TBL] [Abstract][Full Text] [Related]
7. Postoperative seizure in high grade glioma patients treated with BCNU wafers. A mono-institutional experience.
Della Puppa A; Denaro L; Rossetto M; Ciccarino P; Manara R; Lombardi G; Del Moro G; Rotilio A; d'Avella D; Scienza R
J Neurooncol; 2011 Nov; 105(2):275-80. PubMed ID: 21505945
[TBL] [Abstract][Full Text] [Related]
8. First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience.
Bock HC; Puchner MJ; Lohmann F; Schütze M; Koll S; Ketter R; Buchalla R; Rainov N; Kantelhardt SR; Rohde V; Giese A
Neurosurg Rev; 2010 Oct; 33(4):441-9. PubMed ID: 20706757
[TBL] [Abstract][Full Text] [Related]
9. Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience.
Sabel M; Giese A
Curr Med Res Opin; 2008 Nov; 24(11):3239-57. PubMed ID: 18940042
[TBL] [Abstract][Full Text] [Related]
10. Incorporating BCNU wafers into malignant glioma treatment: European case studies.
Balossier A; Dörner L; Emery E; Heese O; Mehdorn HM; Menei P; Singh J
Clin Drug Investig; 2010; 30(3):195-204. PubMed ID: 20155992
[TBL] [Abstract][Full Text] [Related]
11. Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient management.
Kleinberg LR; Weingart J; Burger P; Carson K; Grossman SA; Li K; Olivi A; Wharam MD; Brem H
Cancer Invest; 2004; 22(1):1-9. PubMed ID: 15069758
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of serial changes on computed tomography and magnetic resonance imaging after implantation of carmustine wafers in patients with malignant gliomas for differential diagnosis of tumor recurrence.
Ohue S; Kohno S; Inoue A; Yamashita D; Suehiro S; Seno T; Kumon Y; Kikuchi K; Ohnishi T
J Neurooncol; 2016 Jan; 126(1):119-126. PubMed ID: 26384812
[TBL] [Abstract][Full Text] [Related]
13. Tumor bed cyst formation after BCNU wafer implantation: report of two cases.
Engelhard HH
Surg Neurol; 2000 Mar; 53(3):220-4. PubMed ID: 10773252
[TBL] [Abstract][Full Text] [Related]
14. The influence of carmustine wafer implantation on tumor bed cysts and peritumoral brain edema.
Hasegawa Y; Iuchi T; Sakaida T; Yokoi S; Kawasaki K
J Clin Neurosci; 2016 Sep; 31():67-71. PubMed ID: 27430412
[TBL] [Abstract][Full Text] [Related]
15. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.
Westphal M; Hilt DC; Bortey E; Delavault P; Olivares R; Warnke PC; Whittle IR; Jääskeläinen J; Ram Z
Neuro Oncol; 2003 Apr; 5(2):79-88. PubMed ID: 12672279
[TBL] [Abstract][Full Text] [Related]
16. Management of tumor bed cysts after chemotherapeutic wafer implantation. Report of four cases.
McGirt MJ; Villavicencio AT; Bulsara KR; Friedman HS; Friedman AH
J Neurosurg; 2002 May; 96(5):941-5. PubMed ID: 12005403
[TBL] [Abstract][Full Text] [Related]
17. The role of interstitial BCNU chemotherapy in the treatment of malignant glioma.
Engelhard HH
Surg Neurol; 2000 May; 53(5):458-64. PubMed ID: 10874145
[TBL] [Abstract][Full Text] [Related]
18. Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial.
Olivi A; Grossman SA; Tatter S; Barker F; Judy K; Olsen J; Bruce J; Hilt D; Fisher J; Piantadosi S;
J Clin Oncol; 2003 May; 21(9):1845-9. PubMed ID: 12721262
[TBL] [Abstract][Full Text] [Related]
19. Symptomatic Remote Cyst after BCNU Wafer Implantation for Malignant Glioma.
Matsumura H; Ishikawa E; Matsuda M; Sakamoto N; Akutsu H; Takano S; Matsumura A
Neurol Med Chir (Tokyo); 2018 Jun; 58(6):270-276. PubMed ID: 29780071
[TBL] [Abstract][Full Text] [Related]
20. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial.
Westphal M; Ram Z; Riddle V; Hilt D; Bortey E;
Acta Neurochir (Wien); 2006 Mar; 148(3):269-75; discussion 275. PubMed ID: 16482400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
